Shanghai Allist Pharmaceuticals Co., Ltd. Share Price
Equities
688578
CNE100005XJ7
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 97.63 CNY | +3.83% |
|
+8.48% | -6.26% |
| 03-03 | Shanghai Allist Pharmaceuticals sees Q1 net profit up 43.7% Y/Y | RE |
| 02-27 | Shanghai Allist Pharmaceuticals' Attributable Profit Jumps 53% in 2025 | MT |
| Capitalization | 43.93B 6.39B 5.49B 4.96B 4.75B 8.67B 587B 8.95B 58.41B 23.39B 281B 23.98B 23.47B 1,007B | P/E ratio 2025 |
21.5x | P/E ratio 2026 * | 19.1x |
|---|---|---|---|---|---|
| Enterprise value | 43.93B 6.39B 5.49B 4.96B 4.75B 8.67B 587B 8.95B 58.41B 23.39B 281B 23.98B 23.47B 1,007B | EV / Sales 2025 |
9.06x | EV / Sales 2026 * | 7.19x |
| Free-Float |
40.99% | Yield 2025 * |
0.41% | Yield 2026 * | 0.47% |
| 1 day | +3.83% | ||
| 1 week | +8.48% | ||
| Current month | +5.31% | ||
| 1 month | +1.83% | ||
| 3 months | -1.51% | ||
| 6 months | -14.10% | ||
| Current year | -6.26% |
| 1 week | 92.81 |  | 100 |
| 1 month | 89.59 | | 101.74 |
| Current year | 89.59 | | 110.56 |
| 1 year | 72.38 | | 122.2 |
| 3 years | 22.16 | | 122.2 |
| 5 years | 14.81 | | 122.2 |
| 10 years | 14.81 | | 122.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jin Hao Du
CEO | Chief Executive Officer | 72 | 13/09/2022 |
Feng Xu
PRN | Corporate Officer/Principal | 61 | 31/12/2016 |
Jie Hu
PRN | Corporate Officer/Principal | 51 | 10/03/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
Jun Yan
BRD | Director/Board Member | 44 | 27/11/2019 |
Jin Hao Du
CHM | Chairman | 72 | 21/03/2004 |
Rong Gang Xie
BRD | Director/Board Member | 40 | 27/11/2019 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.83% | +8.48% | +21.52% | +292.09% | 6.13B | |
| +1.36% | -0.81% | +20.33% | +97.71% | 44.74B | |
| +3.35% | +0.43% | +51.85% | +17.36% | 39.46B | |
| +0.50% | -2.14% | +96.87% | +700.06% | 30.85B | |
| -17.88% | -16.74% | -20.37% | -34.18% | 25.64B | |
| -0.44% | +3.29% | +51.29% | -27.37% | 18.74B | |
| +3.74% | +1.33% | +17.58% | -27.37% | 16.45B | |
| +0.43% | +21.20% | +63.60% | +191.30% | 12.22B | |
| +3.88% | +8.07% | -9.23% | +995.97% | 12.19B | |
| -0.44% | +18.33% | +68.22% | - | 11.33B | |
| Average | -0.17% | +2.18% | +36.17% | +245.06% | 21.77B | |
| Weighted average by Cap. | -0.58% | +0.17% | +37.85% | +199.02% |
| 2025 | 2026 * | |
|---|---|---|
| Net sales | 5.11B 743M 638M 577M 552M 1.01B 68.24B 1.04B 6.79B 2.72B 32.72B 2.79B 2.73B 117B | 6.11B 889M 763M 690M 660M 1.21B 81.61B 1.24B 8.12B 3.25B 39.13B 3.33B 3.26B 140B |
| Net income | 1.99B 290M 249M 225M 216M 394M 26.65B 406M 2.65B 1.06B 12.77B 1.09B 1.07B 45.74B | 2.3B 334M 287M 260M 248M 454M 30.71B 468M 3.06B 1.22B 14.72B 1.25B 1.23B 52.71B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/03/26 | 97.63 ¥ | +3.83% | 6,274,285 |
| 09/03/26 | 94.03 ¥ | -3.39% | 6,063,802 |
| 06/03/26 | 97.33 ¥ | +0.92% | 5,972,693 |
| 05/03/26 | 96.44 ¥ | -3.61% | 8,103,940 |
| 04/03/26 | 100.05 ¥ | +11.17% | 14,035,440 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Equities
- 688578 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition